Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OGI 
OrganiGram Holdings Inc (OGI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: OGI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.8
1 Year Target Price $8.8
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -40.2% | Avg. Invested days 26 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 222.48M USD | Price to earnings Ratio 166 | 1Y Target Price 8.8 |
Price to earnings Ratio 166 | 1Y Target Price 8.8 | ||
Volume (30-day avg) 4 | Beta 2.07 | 52 Weeks Range 0.85 - 2.00 | Updated Date 09/14/2025 |
52 Weeks Range 0.85 - 2.00 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.01 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.47% | Operating Margin (TTM) -2.97% |
Management Effectiveness
Return on Assets (TTM) -5.56% | Return on Equity (TTM) -54.53% |
Valuation
Trailing PE 166 | Forward PE 135.14 | Enterprise Value 201848887 | Price to Sales(TTM) 0.99 |
Enterprise Value 201848887 | Price to Sales(TTM) 0.99 | ||
Enterprise Value to Revenue 1.25 | Enterprise Value to EBITDA 9.27 | Shares Outstanding 134022000 | Shares Floating 93855968 |
Shares Outstanding 134022000 | Shares Floating 93855968 | ||
Percent Insiders 32.26 | Percent Institutions 6.05 |
Upturn AI SWOT
OrganiGram Holdings Inc
Company Overview
History and Background
OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, New Brunswick, Canada. It initially focused on medical cannabis production and has since expanded into recreational cannabis products following legalization in Canada. OrganiGram was one of the first licensed producers in Eastern Canada.
Core Business Areas
- Canadian Cannabis Operations: Cultivation, production, and sale of cannabis products for both medical and recreational markets in Canada.
- International Operations: Export of cannabis products to international markets, focusing on medical cannabis.
- Product Development and Innovation: Research and development of new cannabis products and technologies.
Leadership and Structure
The company is led by a board of directors and a management team. Key executives include the CEO, CFO, and Chief Commercial Officer. The organizational structure is divided into departments such as cultivation, production, sales, marketing, finance, and research & development.
Top Products and Market Share
Key Offerings
- Dried Flower: A variety of cannabis strains in dried flower form. Competitors include Tilray (TLRY) and Canopy Growth (CGC). Market share difficult to pinpoint, but OrganiGram is a significant player in the Canadian market.
- Market Share: Unknown
- Edibles: Cannabis-infused edibles such as chocolates and gummies. Competitors include Wana Brands (Privately Held) and Aurora Cannabis (ACB). These products often have higher margins but face regulatory hurdles.
- Market Share: Unknown
- Market Share: Unknown
- Vapes: Cannabis vape products. Competitors include Auxly Cannabis Group (CBWTF) and Cronos Group (CRON). Revenue from vapes is not publicly broken out specifically by OrganiGram, but it contributes significantly to overall sales.
- Concentrates: Cannabis concentrates like hash and oils, cater to experienced cannabis users, are potent, and offer different intake methods. Competitors include Aphria and Supreme Cannabis.
- Market Share: Unknown
Market Dynamics
Industry Overview
The cannabis industry is rapidly evolving, with increasing legalization and acceptance globally. It is characterized by regulatory uncertainty, competition from both legal and illegal sources, and fluctuating consumer demand. The US market is still federal illegal.
Positioning
OrganiGram positions itself as a premium cannabis producer with a focus on quality and innovation. They differentiate themselves through unique production methods, such as their indoor growing facility and innovative product formats. OrganiGram is expanding its global reach.
Total Addressable Market (TAM)
Estimates vary widely, but the global legal cannabis market is projected to reach hundreds of billions of dollars within the next decade. OrganiGram is positioned to capture a share of this growth through its cultivation capacity, product innovation, and international expansion efforts.
Upturn SWOT Analysis
Strengths
- Strong brand reputation in Canada
- Innovative product development
- State-of-the-art production facilities
- Strategic partnerships
- Growing international presence
Weaknesses
- Dependence on the Canadian market
- Limited profitability
- Fluctuations in quarterly earnings
- Vulnerability to regulatory changes
- Price competition from other producers
Opportunities
- Further international expansion
- Increased legalization of cannabis in new markets
- Development of new cannabis-based products
- Strategic acquisitions and partnerships
- Growing demand for medical cannabis
Threats
- Intense competition from other cannabis producers
- Regulatory uncertainty and changes
- Price erosion in the cannabis market
- Economic downturns impacting consumer spending
- Illicit market competition
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- ACB
- CRON
Competitive Landscape
OrganiGram faces intense competition from larger and well-established cannabis companies. Their advantages include innovative production methods, a strong brand in Canada, and international partnerships. Disadvantages include their smaller size compared to competitors and dependence on the Canadian market.
Major Acquisitions
Laurentian Organic Inc.
- Year: 2024
- Acquisition Price (USD millions): 27.5
- Strategic Rationale: The acquisition allows OrganiGram to build on its strategy to develop novel products, including dried flower and hash, while also continuing to deliver on its commitment to profitable growth.
Growth Trajectory and Initiatives
Historical Growth: Unknown
Future Projections: Unknown
Recent Initiatives: Recent initiatives may include facility expansion, new product launches, international partnerships, and strategic investments in related businesses.
Summary
OrganiGram is a mid-sized cannabis company with a strong foothold in the Canadian market, known for its innovation and strategic partnerships. While facing intense competition and regulatory challenges, OrganiGram is actively expanding internationally and developing new product lines. Profitability remains a challenge, but strategic acquisitions and cost-cutting measures are being implemented. The company's ability to scale its operations and adapt to evolving market conditions will be crucial for its long-term success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry News
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. The cannabis industry is rapidly evolving, and market conditions are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OrganiGram Holdings Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2014-08-27 | CEO & Director Ms. Beena G. Goldenberg | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1178 | Website https://www.organigram.ca |
Full time employees 1178 | Website https://www.organigram.ca | ||
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.